205 related articles for article (PubMed ID: 8725697)
1. Prolonged artificial liver support in a child with fulminant hepatic failure.
Okamoto K; Kurose M; Ikuta Y; Ogata K; Harada T; Takeda K; Sato T
ASAIO J; 1996; 42(3):233-5. PubMed ID: 8725697
[TBL] [Abstract][Full Text] [Related]
2. Development of reliable artificial liver support (ALS)--plasma exchange in combination with hemodiafiltration using high-performance membranes.
Yoshiba M; Sekiyama K; Iwamura Y; Sugata F
Dig Dis Sci; 1993 Mar; 38(3):469-76. PubMed ID: 8444078
[TBL] [Abstract][Full Text] [Related]
3. [Effective continuous hemofiltration and plasma exchange for the treatment of subacute type fulminant hepatic failure].
Ogawa R; Kishikawa T; Kudo J; Inaba S; Takamatsu Y; Hirata Y; Yoshimatsu H; Ishibashi H; Taniyama T; Zaitsu A
Fukuoka Igaku Zasshi; 1992 Aug; 83(8):338-42. PubMed ID: 1398429
[TBL] [Abstract][Full Text] [Related]
4. Artificial liver support system using large buffer volumes removes significant glutamine and is an ideal bridge to liver transplantation.
Inoue K; Kourin A; Watanabe T; Yamada M; Yoshiba M
Transplant Proc; 2009; 41(1):259-61. PubMed ID: 19249529
[TBL] [Abstract][Full Text] [Related]
5. [Artificial liver support system for acute-on-chronic liver failure combined with successful liver transplantation in stage III - IV hepatic encephalopathy: an analysis of 14 cases].
Wang YH; Zhu X; Feng DY; Wu BQ
Zhonghua Gan Zang Bing Za Zhi; 2018 Sep; 26(9):676-679. PubMed ID: 30481865
[No Abstract] [Full Text] [Related]
6. Complete recovery from fulminant hepatic failure with severe coma by living donor liver transplantation.
Kobayashi S; Ochiai T; Hori S; Suzuki T; Shimizu T; Gunji Y; Shimada H; Kanazawa M; Ogawa A; Kohno Y; Hirasawa H; Oda S; Tanaka K
Hepatogastroenterology; 2003; 50(50):515-8. PubMed ID: 12749261
[TBL] [Abstract][Full Text] [Related]
7. Favorable effect of new artificial liver support on survival of patients with fulminant hepatic failure.
Yoshiba M; Inoue K; Sekiyama K; Koh I
Artif Organs; 1996 Nov; 20(11):1169-72. PubMed ID: 8908326
[TBL] [Abstract][Full Text] [Related]
8. Usefulness of artificial liver support for pretransplant patients with fulminant hepatic failure.
Sekido H; Matsuo K; Takeda K; Ueda M; Morioka D; Kubota T; Tanaka K; Endo I; Togo S; Shimada H
Transplant Proc; 2004 Oct; 36(8):2355-6. PubMed ID: 15561247
[TBL] [Abstract][Full Text] [Related]
9. Hemodiafiltration treatment of deep hepatic coma by protein passing membrane: case report.
Yoshiba M; Yamada H; Yoshikawa Y; Fujiwara K; Toda G; Oka H; Sanjo T; Yamazaki Z; Idezuki Y; Inoue N
Artif Organs; 1986 Oct; 10(5):417-9. PubMed ID: 3789963
[TBL] [Abstract][Full Text] [Related]
10. [Effectiveness of combined plasma exchange treatment in fulminant viral hepatitis].
Markus R; Baumgarten R; Fengler JD; Bartke D; Binus R; Fischer J; Kilger B; Miersch H
Dtsch Z Verdau Stoffwechselkr; 1985; 45(5):197-204. PubMed ID: 4085389
[TBL] [Abstract][Full Text] [Related]
11. High-volume plasmapheresis and acute liver transplantation in fulminant hepatic failure.
Larsen FS; Hansen BA; Jørgensen LG; Secher NH; Kirkegaard P; Tygstrup N
Transplant Proc; 1994 Jun; 26(3):1788. PubMed ID: 8030135
[No Abstract] [Full Text] [Related]
12. Living-related liver transplantation for patients with fulminant and subfulminant hepatic failure.
Miwa S; Hashikura Y; Mita A; Kubota T; Chisuwa H; Nakazawa Y; Ikegami T; Terada M; Miyagawa S; Kawasaki S
Hepatology; 1999 Dec; 30(6):1521-6. PubMed ID: 10573533
[TBL] [Abstract][Full Text] [Related]
13. [Acute liver failure: current hepatological-surgical therapy results].
Lauchart W
Schweiz Rundsch Med Prax; 1992 Jun; 81(24):802-3. PubMed ID: 1604098
[TBL] [Abstract][Full Text] [Related]
14. High-flow-rate haemodiafiltration as a brain-support therapy proceeding to liver transplantation for hyperacute fulminant hepatic failure.
Sadamori H; Yagi T; Inagaki M; Shima Y; Matsuda H; Tanaka N; Sakaguchi K; Tsuji T; Matsumi M; Katayama H; Hirakawa N
Eur J Gastroenterol Hepatol; 2002 Apr; 14(4):435-9. PubMed ID: 11943960
[TBL] [Abstract][Full Text] [Related]
15. [Liver protection and liver transplantation from a living donor for the treatment of acute hepatic failure].
Inaba S
Masui; 1998 Dec; 47 Suppl():S235-9. PubMed ID: 9921194
[No Abstract] [Full Text] [Related]
16. Effect of treatment with the Molecular Adsorbents Recirculating System on arterial amino acid levels and cerebral amino acid metabolism in patients with hepatic encephalopathy.
Schmidt LE; Tofteng F; Strauss GI; Larsen FS
Scand J Gastroenterol; 2004 Oct; 39(10):974-80. PubMed ID: 15513337
[TBL] [Abstract][Full Text] [Related]
17. [Hepatic encephalopathy in fulminant liver failure. Clinical aspects and therapeutic approaches].
Bode JC
Z Gastroenterol Verh; 1991 Mar; 26():10-3. PubMed ID: 1714112
[No Abstract] [Full Text] [Related]
18. [Apheresis treatment for fulminant hepatitis].
Tateishi Y; Hirasawa H; Nitta M
Nihon Rinsho; 2004 May; 62 Suppl 5():462-6. PubMed ID: 15197964
[No Abstract] [Full Text] [Related]
19. Role of infection and exchange transfusion in fulminant hepatic failure.
de Silva DG; Fernando AJ; Devasiri IV
Ceylon Med J; 1993 Dec; 38(4):188-90. PubMed ID: 8143336
[TBL] [Abstract][Full Text] [Related]
20. Bridging use of plasma exchange and continuous hemodiafiltration before living donor liver transplantation in fulminant Wilson's disease.
Nagata Y; Uto H; Hasuike S; Ido A; Hayashi K; Eto T; Hamakawa T; Tanaka K; Tsubouchi H
Intern Med; 2003 Oct; 42(10):967-70. PubMed ID: 14606709
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
